Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

bioAffinity Technologies, Inc. (BIAF) vs iSpecimen Inc. (ISPC)

bioAffinity Technologies, Inc. and iSpecimen Inc. are both Diagnostics & Research companies. bioAffinity Technologies, Inc. is the larger, with a market value of $9.0M against $3.1M — 2.9× the size. bioAffinity Technologies, Inc. grew revenue faster over the last twelve months: −23.2% against −92.1%. bioAffinity Technologies, Inc. has the higher net margin (−257.3% vs −2,449.0%) and the lower return on invested capital (−408.7% vs 0.00%). Across the 17 metrics below, bioAffinity Technologies, Inc. leads on 11 and iSpecimen Inc. on 6.

Valuation

Metric BIAF ISPC Diagnostics & Research median
P/E n/m n/m 33.95
P/S 0.47 3.77 4.87
P/B 0.73 1.01 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA n/m 0.31 25.20
EV/Sales 0.15 (5.55) 5.66
Earnings yield (1,380.14%) (4,479.37%) (1.75%)
Free cash flow yield (418.18%) (617.94%) (0.13%)

Profitability

Metric BIAF ISPC Diagnostics & Research median
Gross margin 34.61% (108.26%) 50.89%
Operating margin (209.82%) (2,020.05%) (8.57%)
Net margin (257.33%) (2,449.02%) (6.37%)
Free cash flow margin (195.90%) (1,866.61%) 0.00%
Return on equity (1,860.15%) (968.44%) (2.92%)
Return on assets (245.51%) (170.09%) (6.71%)
Return on invested capital (408.67%) 0.00% 0.00%

Growth

Metric BIAF ISPC Diagnostics & Research median
Revenue growth (TTM) (23.18%) (92.11%) 7.69%
EPS growth (last fiscal year) 61.55% 87.03% —
Revenue growth, 5-year CAGR — (25.10%) 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BIAF ISPC Diagnostics & Research median
Debt to equity 0.15 0.00 0.11
Current ratio 1.44 0.82 2.02
Net debt to EBITDA 0.57 0.95 0.78

Dividend

Metric BIAF ISPC Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio — 0.00 0.00

Size

Metric BIAF ISPC Diagnostics & Research median
Market cap 9.00m 3.12m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack